Related Experiment Video
Updated: Jul 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Antimicrobial resistance in tuberculosis: an international perspective
Paul D van Helden1, Peter R Donald, Thomas C Victor
1Molecular Biology and Human Genetics, MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences, Stellenbosch University, PO Box 19063, Tygerberg 7505, South Africa. pvh@sun.ac.za
Drug-resistant tuberculosis poses a significant threat, necessitating earlier diagnosis and effective, shorter treatments to combat its spread. This review explores challenges and advancements in managing drug-resistant tuberculosis.
Area of Science:
- Public Health
- Infectious Diseases
- Microbiology
Background:
- Drug-resistant tuberculosis (DR-TB) is a growing global health crisis.
- Increasing incidence of TB exacerbates the challenge of DR-TB.
- Lack of early diagnosis and effective treatment options hinder TB control.
Purpose of the Study:
- To address the epidemic of drug resistance in tuberculosis.
- To discuss inherent difficulties in treating drug-resistant tuberculosis.
- To highlight controversies, new findings, and future perspectives in DR-TB management.
Main Methods:
- Literature review and synthesis of current research on drug-resistant tuberculosis.
- Analysis of challenges in diagnosis and treatment of DR-TB.
- Exploration of emerging technologies and interventions for DR-TB.
Main Results:
- Drug resistance is a major obstacle to global tuberculosis control.
- Early identification of patients with drug-resistant strains is crucial.
- Shorter, effective treatment regimens with minimal risk are needed.
Conclusions:
- Active interventions, new technologies, and improved diagnostic tools are essential for combating DR-TB.
- Addressing controversies and incorporating new findings can advance treatment strategies.
- Future perspectives emphasize proactive management and community health protection.
Related Concept Videos
Tuberculosis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: